CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company
BIOMERICA INC
Sign in to watch- Ticker
- BMRA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 952645573
- Phone
- 9493792875
- Business address
- 17571 VON KARMAN AVENUE, IRVINE, CA, 92614
- 4 Option exercise Chief Executive Officer acquired 75,000 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 15,000 shares (option exercise)
- 10QSB Other 10QSB
- 4/A Open-market sale Secretary sold 4,500 shares at an average $1.27 ($5,725)
- 4 Open-market sale Secretary sold 2,500 shares at $1.25 ($3,125)
- 4 Returned to the company Secretary returned 4,500 shares (to the company)
- 10QSB Other 10QSB
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale President - Diagnostics sold 25,000 shares at $1.68 ($42,050)
- 10QSB Other 10QSB
- DEF 14A Proxy Proxy Statement
- 10KSB Other 10KSB
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President - Diagnostics sold 1,579 shares at $0.80 ($1,263)
- 8-K Event Executive or director change
- 4 Open-market buy Director bought 12,000 shares at an average $0.74 ($8,850)
- 4 Open-market sale President - Diagnostics sold 5,000 shares at $0.80 ($4,000)
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 23 of 31 · 605 filings